Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study
Authors:
- 29 December 2012
- journal article
- research article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 69 (3) , 451-458
Abstract
Stem cells with the ability to differentiate into insulin-producing cells (IPCs) are becoming the most promising therapy for diabetes mellitus and reduce the major limitations of availability and allogeneic rejection of beta cell transplantations. Mesenchymal stem cells (MSCs) are pluripotent stromal cells with the ability to proliferate and differentiate into a variety of cell types including endocrine cells of the pancreas. This study sought to inspect the in vitro differentiation of human adipose-derived tissue stem cells into IPCs which could provide an abundant source of cells for the purpose of diabetic cell therapy in addition to avoid immunological rejection. Adipose-derived MSCs were obtained from liposuction aspirates and induced to differentiate into insulin-secreting cells under a three-stage protocol based on a combination of low-glucose DMEM medium, β-mercaptoethanol, and nicotinamide for pre-induction and high-glucose DMEM, β-mercaptoethanol, nicotinamide, and exendin-4 for induction stages of differentiation. Differentiation was evaluated by the analysis of morphology, dithizone staining, RT-PCR, and immunocytochemistry. Morphological changes including typical islet-like cell clusters were observed by phase-contrast microscope at the end of differentiation protocol. Based on dithizone staining, differentiated cells were positive and undifferentiated cells were not stained. Furthermore, RT-PCR results confirmed the expression of insulin, PDX1, Ngn3, PAX4, and GLUT2 in differentiated cells. Moreover, insulin production by the IPCs was confirmed by immunocytochemistry analysis. It is concluded that adipose-derived MSCs could differentiate into insulin-producing cells in vitro.Keywords
This publication has 35 references indexed in Scilit:
- Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseasesAutoimmunity Reviews, 2011
- Improved differentiation protocol of rat bone marrow precursors to functional islet like cellsStem Cell Studies, 2011
- Immunomodulation by Mesenchymal Stem CellsDiabetes, 2008
- In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cellsTranslational Research, 2008
- Isolation of Human Mesenchymal Stem Cells from Bone and Adipose Tissue2008
- Immune responses to an encapsulated allogeneic islet β-cell line in diabetic NOD miceBiochemical and Biophysical Research Communications, 2006
- Islet Transplantation in Type 1 Diabetes Mellitus Using Cultured Islets and Steroid‐Free Immunosuppression: Miami ExperienceAmerican Journal of Transplantation, 2005
- Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 DiabetesDiabetes Care, 2005
- Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytesBiochemical and Biophysical Research Communications, 2004
- Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cellsWorld Journal of Gastroenterology, 2004